Argent BioPharma Limited
Research Argent BioPharma Limited (H5O0) on Bullrun: market cap EUR 2.59M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerH5O0
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 2.59M
- Financial periodFY2025
- RevenueEUR 583.45K
- Revenue growth-34.5%
- Net income-EUR 17.84M
- Free cash flow-EUR 9.28M
- Gross margin76.5%
Valuation Snapshot
latest market cap is EUR 2.59M.
About Argent BioPharma Limited
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy;
Frequently asked questions
What is Argent BioPharma Limited's market cap?
Argent BioPharma Limited's market capitalization is EUR 2.59M.
What does Argent BioPharma Limited do?
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally.